In contrast, Cybulski and colleagues [20] analyzed two founder truncations, c.1100delC and c.444+1G>A, and the p.I157T missense variant in a large group of Polish patients and characterized CHEK2 as a multi-organ cancer susceptibility gene. The gene discussed is CHEK2; the disease is cancer.